创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Characterization of SCID Mouse NK Efficacy Model

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-30 16:27
  • Views:

(Summary description)InnoModels Biotechnology has always been committed to promoting cutting-edge biomedical research and providing scientists with advanced research tools and services. Among them, the company's SCID mouse NK efficacy model is an innovation that has attracted much attention in the field of disease treatment research. In this paper, we will introduce the unique features of this model and its potential application in the field of immunotherapy

InnoModels Biotechnology: Characterization of SCID Mouse NK Efficacy Model

(Summary description)InnoModels Biotechnology has always been committed to promoting cutting-edge biomedical research and providing scientists with advanced research tools and services. Among them, the company's SCID mouse NK efficacy model is an innovation that has attracted much attention in the field of disease treatment research. In this paper, we will introduce the unique features of this model and its potential application in the field of immunotherapy

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-30 16:27
  • Views:
Information

InnoModels Biotechnology has always been committed to promoting cutting-edge biomedical research and providing scientists with advanced research tools and services. Among them, the company's SCID mouse NK efficacy model is an innovation that has attracted much attention in the field of disease treatment research. In this paper, we will introduce the unique features of this model and its potential application in the field of immunotherapy.
1. Special properties of SCID mice
SCID mice (Severe Combined Immunodeficiency Mice) are a mouse model naturally defective in the effective T and B cell immune system. This severe immunodeficiency makes them an ideal model for studying areas such as immunology, transplantation and tumor biology. In the research at Transmooker Biologics, this mouse model is carefully selected and further modified by gene editing techniques to meet the needs of specific areas of research.
2. Importance of NK cells in immunotherapy
Natural killer cells (NK cells) play a key role in the immune system and have important functions in fighting infections and tumors. Therefore, the SCID mouse NK pharmacodynamic model is particularly focused on simulating and studying the biological behavior of NK cells. The model provides a unique platform for scientists to gain insights into the functions of NK cells, their regulatory mechanisms, and the effects that drugs have on them.

 


3. Highly customized research services
The SCID mouse NK efficacy model from InnoModels Biotechnology is not only an animal model, but also a highly customized research service. Researchers can choose different experimental designs and drug treatment protocols according to specific experimental needs to ensure the applicability of the model and the reliability of experimental results.
4. Advanced data reporting and analysis
In order to better support researchers, InnoModels Biotechnology provides detailed data reporting and analysis services. These reports not only include basic experimental data, but also provide an in-depth interpretation of the drug's effect on NK cell function, providing researchers with clear conclusions and directions for their studies.
5. Ethical Compliance and Research Ethics
InnoModels Biotechnology always puts ethical compliance and research ethics in the first place. When using the SCID mouse NK efficacy model for research, the company ensures that all experimental activities comply with relevant regulations and ethical norms to safeguard the legitimacy and sustainability of the research.
Conclusion
The SCID Mouse NK Efficacy Model from InnoModels Biotechnology not only highlights the company's leadership in the field of genetically engineered homologous models, but also provides a unique platform for scientists to comprehensively understand NK cell biology and conduct immunotherapy research. Its unique features and services will provide the research community with new perspectives and drive innovation in the field of immunotherapy.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司